Designers are loving the rich red and green marble varieties that are a hallmark of Piero Portaluppi’s Rationalist ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

Here, color expert Lori Weitzner spotlights a few feel-good palettes, starting with blues. “Blues feel comfortable, familiar, and protective,” she says. Read on for how to use blues ...

From navy blues and plum purples to vivid pops of bright white or light yellow — these saturated palettes look to the stars ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats. Trump ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Discover curated Spring 2025 capsule wardrobes tailored to all 12 seasonal color palettes! Whether you’re a Bright Spring embracing bold freshness, a Soft Summer layering misty pastels, or a Dark ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...